What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...

Objective Acute myocardial infarction (AMI) is the leading cause of death and disability globally. There is increasing evidence from observational studies that influenza infection is associated with ...

Researchers have found in a new study that HbA1c ma serve as an independent predictor of major adverse cardiovascular events ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...